RhumbLine Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.76M | Buy |
59,508
+2,052
| +4% | +$233K | 0.01% | 1256 |
|
|
2025
Q1 | $6.04M | Sell |
57,456
-1,989
| -3% | -$209K | 0.01% | 1257 |
|
|
2024
Q4 | $6.37M | Sell |
59,445
-575
| -1% | -$61.6K | 0.01% | 1300 |
|
|
2024
Q3 | $6.01M | Sell |
60,020
-1,312
| -2% | -$131K | 0.01% | 1331 |
|
|
2024
Q2 | $5.17M | Buy |
61,332
+1,077
| +2% | +$90.7K | ﹤0.01% | 1380 |
|
|
2024
Q1 | $4.4M | Buy |
60,255
+730
| +1% | +$53.4K | ﹤0.01% | 1478 |
|
|
2023
Q4 | $4.25M | Buy |
59,525
+2,398
| +4% | +$171K | ﹤0.01% | 1518 |
|
|
2023
Q3 | $3.42M | Buy |
57,127
+1,628
| +3% | +$97.5K | ﹤0.01% | 1565 |
|
|
2023
Q2 | $4M | Buy |
55,499
+2,458
| +5% | +$177K | ﹤0.01% | 1513 |
|
|
2023
Q1 | $3.9M | Buy |
53,041
+2,342
| +5% | +$172K | ﹤0.01% | 1454 |
|
|
2022
Q4 | $3.39M | Sell |
50,699
-27,058
| -35% | -$1.81M | ﹤0.01% | 1515 |
|
|
2022
Q3 | $4.18M | Buy |
77,757
+1,063
| +1% | +$57.1K | 0.01% | 1340 |
|
|
2022
Q2 | $4.27M | Buy |
76,694
+2,913
| +4% | +$162K | 0.01% | 1331 |
|
|
2022
Q1 | $5.18M | Buy |
73,781
+1,641
| +2% | +$115K | 0.01% | 1291 |
|
|
2021
Q4 | $6.95M | Sell |
72,140
-1,936
| -3% | -$187K | 0.01% | 1182 |
|
|
2021
Q3 | $6.44M | Sell |
74,076
-7,071
| -9% | -$615K | 0.01% | 1198 |
|
|
2021
Q2 | $6.64M | Buy |
81,147
+8,186
| +11% | +$670K | 0.01% | 1270 |
|
|
2021
Q1 | $6.94M | Sell |
72,961
-466
| -0.6% | -$44.3K | 0.01% | 1218 |
|
|
2020
Q4 | $4.56M | Buy |
73,427
+26
| +0% | +$1.61K | 0.01% | 1407 |
|
|
2020
Q3 | $4.37M | Sell |
73,401
-14,264
| -16% | -$848K | 0.01% | 1251 |
|
|
2020
Q2 | $6.12M | Sell |
87,665
-12,337
| -12% | -$861K | 0.01% | 1079 |
|
|
2020
Q1 | $4.54M | Sell |
100,002
-546
| -0.5% | -$24.8K | 0.01% | 1077 |
|
|
2019
Q4 | $6.54M | Sell |
100,548
-4,899
| -5% | -$319K | 0.01% | 1093 |
|
|
2019
Q3 | $6.55M | Sell |
105,447
-981
| -0.9% | -$60.9K | 0.01% | 1039 |
|
|
2019
Q2 | $7.58M | Sell |
106,428
-1,308
| -1% | -$93.1K | 0.01% | 942 |
|
|
2019
Q1 | $8.45M | Sell |
107,736
-612
| -0.6% | -$48K | 0.02% | 860 |
|
|
2018
Q4 | $9.17M | Buy |
108,348
+25,511
| +31% | +$2.16M | 0.02% | 758 |
|
|
2018
Q3 | $14.2M | Sell |
82,837
-3,000
| -3% | -$514K | 0.03% | 543 |
|
|
2018
Q2 | $11.1M | Buy |
85,837
+3,550
| +4% | +$459K | 0.02% | 634 |
|
|
2018
Q1 | $8.48M | Buy |
82,287
+999
| +1% | +$103K | 0.02% | 733 |
|
|
2017
Q4 | $6.94M | Buy |
81,288
+11,529
| +17% | +$985K | 0.01% | 872 |
|
|
2017
Q3 | $5.93M | Buy |
69,759
+4,743
| +7% | +$403K | 0.01% | 938 |
|
|
2017
Q2 | $4.92M | Buy |
65,016
+930
| +1% | +$70.4K | 0.01% | 1009 |
|
|
2017
Q1 | $4.23M | Buy |
64,086
+16,815
| +36% | +$1.11M | 0.01% | 1107 |
|
|
2016
Q4 | $3M | Buy |
47,271
+2,932
| +7% | +$186K | 0.01% | 1210 |
|
|
2016
Q3 | $2.82M | Buy |
44,339
+2,770
| +7% | +$176K | 0.01% | 1192 |
|
|
2016
Q2 | $3.09M | Buy |
41,569
+2,252
| +6% | +$168K | 0.01% | 1087 |
|
|
2016
Q1 | $2.63M | Buy |
39,317
+754
| +2% | +$50.4K | 0.01% | 1199 |
|
|
2015
Q4 | $2.61M | Buy |
38,563
+4,562
| +13% | +$309K | 0.01% | 1184 |
|
|
2015
Q3 | $1.82M | Buy |
34,001
+899
| +3% | +$48K | 0.01% | 1379 |
|
|
2015
Q2 | $2.08M | Sell |
33,102
-4,726
| -12% | -$298K | 0.01% | 1378 |
|
|
2015
Q1 | $1.82M | Buy |
37,828
+3,759
| +11% | +$181K | 0.01% | 1463 |
|
|
2014
Q4 | $1.13M | Sell |
34,069
-1,162
| -3% | -$38.6K | ﹤0.01% | 1718 |
|
|
2014
Q3 | $1.03M | Sell |
35,231
-2,164
| -6% | -$63.5K | ﹤0.01% | 1737 |
|
|
2014
Q2 | $1.45M | Buy |
37,395
+2,860
| +8% | +$111K | ﹤0.01% | 1582 |
|
|
2014
Q1 | $1.45M | Sell |
34,535
-1,268
| -4% | -$53.2K | ﹤0.01% | 1559 |
|
|
2013
Q4 | $1.18M | Buy |
35,803
+7,117
| +25% | +$234K | ﹤0.01% | 1695 |
|
|
2013
Q3 | $774K | Sell |
28,686
-195
| -0.7% | -$5.26K | ﹤0.01% | 1948 |
|
|
2013
Q2 | $674K | Buy |
+28,881
| New | +$674K | ﹤0.01% | 2040 |
|